Arbutus Biopharma Corp Proceeds from Stock Plans
Arbutus Biopharma Corp (ABUS) reported Proceeds from Stock Plans of $88.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2026-08-12
- Arbutus Biopharma Corp proceeds from stock plans for the quarter ending 2026-06-30 was $0.00.
- Arbutus Biopharma Corp proceeds from stock plans for the quarter ending 2026-03-31 was $88.00K, a 32.82% decline year-over-year.
- Arbutus Biopharma Corp proceeds from stock plans for the quarter ending 2025-12-31 was $0.00.
- Arbutus Biopharma Corp proceeds from stock plans for the quarter ending 2025-09-30 was $50.00K, a 72.97% decline year-over-year.
- Arbutus Biopharma Corp proceeds from stock plans for fiscal 2025 was $181.00K, a 54.29% decline from fiscal 2024.
- Arbutus Biopharma Corp proceeds from stock plans for fiscal 2024 was $396.00K, a 25.98% decline from fiscal 2023.
- Arbutus Biopharma Corp proceeds from stock plans for fiscal 2023 was $535.00K, a 35.44% increase from fiscal 2022.
- Arbutus Biopharma Corp proceeds from stock plans for fiscal 2022 was $395.00K, a 14.32% decline from fiscal 2021.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month | Proceeds from Stock Plans 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $88.00K 10-Q · filed 2026-08-12 | $88.00K derived: sum of 3 quarters · filed 2026-08-12 | $138.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $88.00K 10-Q · filed 2026-05-13 | $88.00K derived: sum of 2 quarters · filed 2026-05-13 | $138.00K derived: sum of 3 quarters · filed 2026-05-13 | $138.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $50.00K derived: sum of 2 quarters · filed 2026-03-23 | $50.00K derived: sum of 3 quarters · filed 2026-08-12 | $181.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $50.00K derived: sum of 2 quarters · filed 2026-08-12 | $181.00K 10-Q · filed 2025-11-13 | $181.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $131.00K 10-Q · filed 2026-08-12 | $131.00K derived: sum of 3 quarters · filed 2026-08-12 | $316.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $131.00K 10-Q · filed 2026-05-13 | $131.00K derived: sum of 2 quarters · filed 2026-05-13 | $316.00K derived: sum of 3 quarters · filed 2026-05-13 | $316.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $185.00K derived: sum of 2 quarters · filed 2026-03-23 | $185.00K derived: sum of 3 quarters · filed 2026-03-23 | $396.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $185.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $185.00K derived: sum of 2 quarters · filed 2025-11-13 | $396.00K 10-Q · filed 2025-11-13 | $350.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $211.00K 10-Q · filed 2025-08-06 | $165.00K derived: sum of 3 quarters · filed 2025-08-06 | $450.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $211.00K 10-Q · filed 2025-05-14 | $165.00K derived: sum of 2 quarters · filed 2025-05-14 | $450.00K derived: sum of 3 quarters · filed 2025-05-14 | $450.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $239.00K derived: sum of 2 quarters · filed 2025-03-27 | $239.00K derived: sum of 3 quarters · filed 2025-03-27 | $535.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $285.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $285.00K derived: sum of 2 quarters · filed 2024-11-06 | $581.00K 10-Q · filed 2024-11-06 | $581.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $296.00K 10-Q · filed 2024-08-08 | $296.00K derived: sum of 3 quarters · filed 2024-08-08 | $455.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $296.00K 10-Q · filed 2024-05-02 | $296.00K derived: sum of 2 quarters · filed 2024-05-02 | $455.00K derived: sum of 3 quarters · filed 2024-05-02 | $455.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $159.00K derived: sum of 2 quarters · filed 2024-03-05 | $159.00K derived: sum of 3 quarters · filed 2024-03-05 | $395.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $159.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $159.00K derived: sum of 2 quarters · filed 2023-11-07 | $395.00K 10-Q · filed 2023-11-07 | $395.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $236.00K 10-Q · filed 2023-08-03 | $236.00K derived: sum of 3 quarters · filed 2023-08-03 | $450.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $236.00K 10-Q · filed 2023-05-04 | $236.00K derived: sum of 2 quarters · filed 2023-05-04 | $450.00K derived: sum of 3 quarters · filed 2023-05-04 | $450.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $214.00K derived: sum of 2 quarters · filed 2023-03-02 | $214.00K derived: sum of 3 quarters · filed 2023-03-02 | $461.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | $214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $214.00K derived: sum of 2 quarters · filed 2022-11-09 | $461.00K 10-Q · filed 2022-11-09 | $461.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $247.00K 10-Q · filed 2022-08-04 | $247.00K derived: sum of 3 quarters · filed 2022-08-04 | $247.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $247.00K 10-Q · filed 2022-05-05 | $247.00K derived: sum of 2 quarters · filed 2022-05-05 | $247.00K derived: sum of 3 quarters · filed 2022-05-05 | $247.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $0.00 derived: sum of 2 quarters · filed 2022-03-03 | $0.00 derived: sum of 3 quarters · filed 2022-03-03 | $0.00 10-K · filed 2022-03-03 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |